Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?

@article{Giannarini2011AntegradePW,
  title={Antegrade perfusion with bacillus Calmette-Gu{\'e}rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?},
  author={Gianluca Giannarini and Thomas M Kessler and Frederic D Birkhaeuser and George N Thalmann and Urs E Studer},
  journal={European urology},
  year={2011},
  volume={60 5},
  pages={955-60}
}
BACKGROUND There is paucity of data on bacillus Calmette-Guérin (BCG) perfusion in patients with non-muscle-invasive urothelial carcinoma (NMIUC) of the upper urinary tract (UUT). OBJECTIVE To assess the long-term results of BCG perfusion in patients with UUT NMIUC in terms of efficacy and tolerability. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of 55 consecutive patients (64 renal units [RUs]) with UUT NMIUC prospectively followed according to a standardised protocol for a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

update

JP O’Donoghue, JP Crew
Eur Urol • 2011

Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Guérin therapy.

International journal of urology : official journal of the Japanese Urological Association • 2006
View 2 Excerpts

Clinical outcome of bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract.

International journal of urology : official journal of the Japanese Urological Association • 2002
View 1 Excerpt

Similar Papers

Loading similar papers…